← All grants

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

National Institutes of Health · Opportunity PAR-24-279

Deadline November 2, 2026 54 days left
Award range Not stated
Total program funding
PostedDecember 9, 2024

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

About this opportunity

This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.

Portfolio context — this listing covers more than this opportunity

This opportunity is funded under Assistance Listing 93.846 (“Arthritis, Musculoskeletal and Skin Diseases Research”), a broad federal program that made about 362 new awards per year over the last five fiscal years (median award $424k). Those figures describe that whole portfolio — not this specific solicitation, so we don't show them as if they were this opportunity's track record.

Applicant counts per solicitation are not published by any federal agency — no one can honestly sell you that number. NIH publishes success rates by institute and activity code — source.

Apply on grants.gov →

Don't want to hunt for grants like this one? Get free deadline alerts for your state and focus areas.

Consultant or grant writer? See the client-ready Opportunity Brief for this grant — actual award sizes vs. the advertised ceiling, who wins, printable "prepared for your client" version.

Similar grants still open

OpportunityAgencyDeadlineAward ceilingEligible
NIH Director’s Pioneer Award (DP1 Clinical Trial Optional) National Institutes of Health September 9, 2026 0d left $700k Nonprofits
Fiscal Year 2027 Expanding Nutrition Services Health Resources and Services Administration September 9, 2026 0d left $350k
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional) National Institutes of Health September 10, 2026 1d left $350k Nonprofits
Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats Office of National Drug Control Policy September 13, 2026 4d left $300k Nonprofits